Loss of the retinoblastoma tumor suppressor: Differential action on transcriptional programs related to cell cycle control and immune function

Oncogene

Volumn 26, Issue 43, 2007, Pages 6307-6318

  Markey, M P ^a   Bergseid, J ^b   Bosco, E E ^a   Stengel, K ^a   Xu, H ^a,c   Mayhew, C N ^a   Schwemberger, S J ^d   Braden, W A ^a   Jiang, Y ^b   Babcock, G F ^a,d   Jegga, A G ^a,c   Aronow, B J ^a,c   Reed, M F ^a   Wang, J Y J ^b   Knudsen, E S ^a,e  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d Shriners Hospital   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cycle; E2F; Inflammation; RB; Transcriptional repression

Indexed keywords

MUTANT PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE EXPRESSION REGULATION; GENE LOSS; GENETIC MODEL; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; KNOCKOUT GENE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; RETINOBLASTOMA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; CELL CYCLE; CELLS, CULTURED; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, KNOCKOUT; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; TRANSCRIPTION, GENETIC; UP-REGULATION;

MURINAE;

EID: 34648840189     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210450     Document Type: Article

References (40)

1. Arany I, Tyring SK. (1996). Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions. Sex Transm Dis 23: 475-480.
2. Batsche E, Moschopoulos P, Desroches J, Bilodeau S, Drouin J. (2005). Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription. J Biol Chem 280: 16088-16095.
3. Black EP, Huang E, Dressman H, Rempel R, Laakso N, Asa SL et al. (2003). Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res 63: 3716-3723.
4. Blais A, Dynlacht BD. (2004). Hitting their targets: an emerging picture of E2F and cell cycle control. Curr Opin Genet Dev 14: 527-532.
5. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. (1998). Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601.
6. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R et al. (2004). A common set of gene regulatory networks links metabolism and growthinh ibition. Mol Cell 16: 399-411.
7. Cam H, Dynlacht BD. (2003). Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 3: 311-316.
8. Chen TT, Wang JY. (2000). Establishment of irreversible growtharrest in myogenic differentiation requires the RB LXCXE-binding function. Mol Cell Biol 20: 5571-5580.
9. Cobrinik D. (2005). Pocket proteins and cell cycle control. Oncogene 24: 2796-2809.
10. Dimova DK, Dyson NJ. (2005). The E2F transcriptional network: old acquaintances withnew faces. Oncogene 24: 2810-2826.
11. Eason DD, Coppola D, Livingston S, Shepherd AT, Blanck G. (2001). Loss of MHC class II inducibility in hyperplastic tissue in Rb-defective mice. Cancer Lett 171: 209-214.
12. Frolov MV, Dyson NJ. (2004). Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117(Part 11): 2173-2181.
13. Iavarone A, King ER, Dai XM, Leone G, Stanley ER, Lasorella A. (2004). Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature 432: 1040-1045.
14. Iovino F, Lentini L, Amato A, Di Leonardo A. (2006). RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Mol Cancer 20: 5:38.
15. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M et al. (2001). Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21: 4684-4699.
16. Jegga AG, Gupta A, Gowrisankar S, Deshmukh MA, Connolly S, Finley K et al. (2005). CisMols Analyzer: identification of compositionally similar cis-element clusters in ortholog conserved regions of coordinately expressed genes. Nucleic Acids Res 33: W408-W411.
17. Jegga AG, Sherwood SP, Carman JW, Pinski AT, Phillips JL, Pestian JP et al. (2002). Detection and visualization of compositionally similar cis-regulatory element clusters in orthologous and coordinately controlled genes. Genome Res 12: 1408-1417.
18. Knudsen ES, Buckmaster C, Chen TT, Feramisco JR, Wang JY. (1998). Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev 12: 2278-2292.
19. Kouzarides T. (1995). Transcriptional control by the retinoblastoma protein. Semin Cancer Biol 6: 91-98.
20. Le Buanec H, D'Anna R, Lachgar A, Zagury JF, Bernard J, Ittele D et al. (1999). HPV-16 E7 but not E6 oncogenic protein triggers bothcellular immunosuppression and angiogenic processes. Biomed Pharmacother 53: 424-431.
21. Lu Y, Ussery GD, Muncaster MM, Gallie BL, Blanck G. (1994). Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogene 9: 1015-1019.
22. Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ et al. (2002). Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res 62: 6587-6597.
23. Mayhew CN, Perkin LM, Zhang X, Sage J, Jacks T, Knudsen ES. (2004). Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. Oncogene 23: 4107-4120.
24. Morris EJ, Dyson NJ. (2001). Retinoblastoma protein partners. Adv Cancer Res 82: 1-54.
25. Nevins JR. (2001). The Rb/E2F pathway and cancer. Hum Mol Genet 10: 699-703.
26. Osborne A, Tschickardt M, Blanck G. (1997). Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter. Nucleic Acids Res 25: 5095-5102.
27. Osborne AR, Zhang H, Fejer G, Palubin KM, Niesen MI, Blanck G. (2004). Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter. J Biol Chem 279: 28911-28919.
28. Qin XQ, Livingston DM, Ewen M, Sellers WR, Arany Z, Kaelin Jr WG. (1995). The transcription factor E2F-1 is a downstream target of RB action. Mol Cell Biol 15: 742-755.
29. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA et al. (2002). E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256.
30. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. (2003). Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424: 223-228.
31. Sherr CJ, McCormick F. (2002). The RB and p53 pathways in cancer. Cancer Cell 2: 103-112.
32. Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN et al. (2000). BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA 97: 7748-7753.
33. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC et al. (2001). The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 8: 303-316.
34. Thomas DM, Yang HS, Alexander K, Hinds PW. (2003). Role of the retinoblastoma protein in differentiation and senescence. Cancer Biol Ther 2: 124-130.
35. Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T. (1997). RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci USA 94: 11268-11273.
36. Vernell R, Helin K, Muller H. (2003). Identification of target genes of the p16INK4A-pRB-E2F pathway. J Biol Chem 278: 46124-46137.
37. Wang JY, Knudsen ES, Welch PJ. (1994). The retinoblastoma tumor suppressor protein. Adv Cancer Res 64: 25-28 5..
38. Welch PJ, Wang JY. (1995). Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol Cell Biol 15: 5542-5551.
39. Xin H, Pramanik R, Choubey D. (2003). Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth. Oncogene 22: 4775-4785.
40. Zhu X, Pattenden S, Bremner R. (1999). pRB is required for interferon-gamma-induction of the MHC class II abeta gene. Oncogene 18: 4940-4947.